Makita Z - Search Results

Year	Number of Results
1982	1
1983	1
1987	1
1988	1
1989	2
1991	5
1992	3
1993	4
1994	2
1995	4
1996	1
1997	3
1998	5
1999	3
2000	5
2001	7
2002	18
2003	4
2004	2
2011	1
2012	2
2013	1
2014	1
2024	0

1

Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial.

Roden M, Weng J, Eilbracht J, Delafont B, Kim G, Woerle HJ, Broedl UC; EMPA-REG MONO trial investigators. Roden M, et al. Lancet Diabetes Endocrinol. 2013 Nov;1(3):208-19. doi: 10.1016/S2213-8587(13)70084-6. Epub 2013 Sep 9. Lancet Diabetes Endocrinol. 2013. PMID: 24622369 Clinical Trial.

2

[OPB-9195].

Takeuchi M, Yamagishi S, Makita Z. Takeuchi M, et al. Among authors: makita z. Nihon Rinsho. 2002 Sep;60 Suppl 9:606-10. Nihon Rinsho. 2002. PMID: 12387058 Review. Japanese. No abstract available.

3

Advanced glycation end products and the pathogenesis of diabetic nephropathy.

Yamagishi S, Takeuchi M, Makita Z. Yamagishi S, et al. Among authors: makita z. Contrib Nephrol. 2001;(134):30-5. doi: 10.1159/000060150. Contrib Nephrol. 2001. PMID: 11665285 Review. No abstract available.

4

Glycation--a sweet tempter for neuronal death.

Kikuchi S, Shinpo K, Takeuchi M, Yamagishi S, Makita Z, Sasaki N, Tashiro K. Kikuchi S, et al. Among authors: makita z. Brain Res Brain Res Rev. 2003 Mar;41(2-3):306-23. doi: 10.1016/s0165-0173(02)00273-4. Brain Res Brain Res Rev. 2003. PMID: 12663085 Review.

5

Advanced glycation endproducts and diabetic nephropathy.

Makita Z, Yanagisawa K, Kuwajima S, Yoshioka N, Atsumi T, Hasunuma Y, Koike T. Makita Z, et al. J Diabetes Complications. 1995 Oct-Dec;9(4):265-8. doi: 10.1016/1056-8727(95)80018-a. J Diabetes Complications. 1995. PMID: 8573743 Review.

6

Alternative routes for the formation of immunochemically distinct advanced glycation end-products in vivo.

Takeuchi M, Makita Z. Takeuchi M, et al. Among authors: makita z. Curr Mol Med. 2001 Jul;1(3):305-15. doi: 10.2174/1566524013363735. Curr Mol Med. 2001. PMID: 11899079 Review.

7

'Toxicity of glucose: is AGE the answer?'.

Makita Z. Makita Z. Nephrol Dial Transplant. 1995;10 Suppl 7:33-7. doi: 10.1093/ndt/10.supp7.33. Nephrol Dial Transplant. 1995. PMID: 8570076 Review.

8

The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis.

Makita Z, Yanagisawa K, Kuwajima S, Bucala R, Vlassara H, Koike T. Makita Z, et al. Nephrol Dial Transplant. 1996;11 Suppl 5:31-3. doi: 10.1093/ndt/11.supp5.31. Nephrol Dial Transplant. 1996. PMID: 9044304 Review.

9

Hemoglobin-AGE: a circulating marker of advanced glycosylation.

Makita Z, Vlassara H, Rayfield E, Cartwright K, Friedman E, Rodby R, Cerami A, Bucala R. Makita Z, et al. Science. 1992 Oct 23;258(5082):651-3. doi: 10.1126/science.1411574. Science. 1992. PMID: 1411574

10

Interferon-gamma-induced apoptosis and activation of THP-1 macrophages.

Inagaki Y, Yamagishi S, Amano S, Okamoto T, Koga K, Makita Z. Inagaki Y, et al. Among authors: makita z. Life Sci. 2002 Oct 11;71(21):2499-508. doi: 10.1016/s0024-3205(02)02042-8. Life Sci. 2002. PMID: 12270755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Results by year